XBiotech Inc.

US$1.89As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:XBITHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (16.45%)
Div yield —
ROE (29.94%)
Biotechnology
Beta (5Y) 0.74
PE TTM —
TSR TTM (19.57%)
Mkt cap US$57.62M
ROIC (250.55%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.98
4.74%
(89.02%)
Sell 2|2|6|3|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.03
23.81%
19.79%
26.25%
23.35%
Revenue$M
3.444
3.619
3.640
3.590
3.50%
5.53%
7.07%
3.99%
Peers (US$57.62M)
Cap (US$)
PE
56.15M
—
Capital
TTM
5Y
10Y
Leveragex
0.665
0.287
0.250
EBIT/Intx
2.885
0.495
0.477
Own earn%
48.99
25.28
27.19
Sh yield%
44.79
47.78
44.54
Owners
Insiders/Inst%
9.46
53.85
Short interest%
5.42
SBC / revenue%
4.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
5–12
$1 testx
−0.1
Incr. ROIC%
8